IGF-1LR3 IG01 0.1mg*10vials

IGF-1 LR3 IG01 0.1mg x 10 Vials

Product Overview

IGF-1 LR3 IG01 is a high-purity long-acting recombinant insulin-like growth factor-1 analog research peptide with the classic Long R3 structural modification. This variant is based on an optimized natural IGF-1 molecular framework, replacing the third amino acid and adding a 13-amino acid N-terminal extension, supporting extended half-life and low IGF-binding protein (IGFBP) binding affinity research. Compared to conventional short-acting IGF-1, IG01 supports endogenous IGFBP3 and IGFBP1 encapsulation and inactivation avoidance research, and free stable targeted binding efficiency in vivo research. It supports traditional growth hormone-dependent pathway activation limitation related studies, directly targeting downstream IGF-1 signaling pathways, serving as an independent material for cell proliferation regulation, metabolic remodeling, and anti-aging mechanism research. The purified 0.1mg standard medium specification is suitable for routine gradient modeling, cell culture intervention, tissue growth studies, and complex peptide synergistic effect validation, applicable to preclinical physiological mechanism and pharmacological research.

Core Research Functions

PI3K/Akt/mTOR Core Downstream Signaling Pathway Activation: Supports PI3K/Akt/mTOR core downstream signaling pathway activation research, and somatic cell proliferation, differentiation, survival, and apoptosis balance independent regulation studies.

Muscle Cell Proliferation and Repair: Supports muscle cell proliferation and repair promotion research, and lean tissue reconstruction and growth acceleration studies.

Peripheral Glucose Uptake and Insulin Signal Transduction Optimization: Supports peripheral glucose uptake and insulin signal transduction optimization research, and insulin resistance metabolic model intervention studies.

Oxidative Stress and Apoptosis Inhibition: Supports oxidative stress and apoptosis inhibition research, and tissue aging delay studies.

Growth Hormone Peptide Synergistic Interaction: Supports growth hormone peptide synergistic interaction research, and growth hormone and insulin-like growth factor-1 axis positive feedback model construction studies, supporting overall metabolic and anabolism intervention effect enhancement research.

Unlike HGH products that indirectly increase IGF-1 levels through pituitary stimulation, IG01 directly provides bioactive long-acting IGF-1, supporting direct rapid sustained cell growth promotion, lean tissue anabolism enhancement, glucose metabolism regulation, and cellular senescence inhibition research. The 0.1mg formulation supports stable long-lasting activity and low experimental variability research, suitable for long-term repetitive intervention studies, providing reproducible standard data for cell biology, metabolic pharmacology, and anti-aging mechanism research.

Core Product Advantages

LR3 Long-Acting Modification Structure: An optimized long-acting LR3 structure supporting endogenous IGFBP protein binding and inactivation resistance research, molecular half-life extension research, and long-lasting effect research, supporting natural IGF-1 short half-life and rapid decay related problem research.

Direct and Independent Pathway Activation: Supports endogenous growth hormone secretion and pituitary function independence related studies. It directly supplements active IGF-1, supporting downstream anabolic and metabolic pathway activation research, faster onset of action research, and significant experimental phenotype research, supporting single growth hormone research material indirect effect related studies.

Classic Balanced Standard 0.1mg Formulation: A universally applicable moderate dose suitable for mainstream laboratory studies, balancing sufficient biological activity and experimental safety. Suitable for daily dose gradient screening, long-term cell intervention, and peptide compound validation, with broad application adaptability.

High-Purity Recombinant Active Peptide Purification Process: Utilizes advanced recombinant protein purification and vacuum freeze-drying technology, ensuring peptide high activity with minimal foreign protein contamination, providing high-purity experimental variables and supporting accurate reliable research conclusions.

Standard Aseptic Integrated Packaging: Packaged in 10-vial aseptic packs. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). With stable activity and long shelf life, it is suitable for university laboratories, preclinical drug development, and bulk wholesale purchases.

Specifications and Quality Control

Format: Lyophilized powder, 0.1mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).